Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-063457
Filing Date
2013-12-18
Accepted
2013-12-18 18:59:12
Documents
1
Period of Report
2013-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 - LAWRENCE P. WENNOGLE rrd397916.html 4  
1 FORM 4 - LAWRENCE P. WENNOGLE rrd397916.xml 4 5136
  Complete submission text file 0001181431-13-063457.txt   6595
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTRA-CELLULAR THERAPIES, INC. 3960 BROADWAY NEW YORK NY 10032
Business Address
Wennogle Lawrence P. (Reporting) CIK: 0001585663 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54896 | Film No.: 131286477